PTX3 expression has been reported in numerous malignancies, including glioma, lung, ovarian, pancreatic, and prostate cancers, as well as myxoid liposarcoma and esophageal squamous cell carcinoma [54]. This evidence concerns the gene PTX3 and prostate carcinoma.